If you’ve been relying on Weight Watchers for your semaglutide weight loss treatment, you’ve probably received some concerning news. In May 2025, Weight Watchers announced they would no longer offer compounded semaglutide through their service, leaving many patients searching for alternatives.
The good news is that while large telehealth companies have stopped offering these medications, local medical practices like Alturas Medical Weight Loss in Meridian continue to provide personalized compounded solutions for patients who need them.
Understanding What Happened to Weight Watchers
Weight Watchers built much of their recent business around offering compounded versions of popular weight loss medications. These included semaglutide (the active ingredient in Ozempic and Wegovy) and tirzepatide (the active ingredient in Mounjaro and Zepbound). However, regulatory changes forced them to shut down this program entirely.
Here’s what happened behind the scenes. Since 2022, these medications were on the FDA’s drug shortage list due to overwhelming demand. This shortage designation allowed large-scale compounding facilities to produce copies of these drugs to meet patient needs. In February 2025, the FDA declared the semaglutide shortage officially resolved, meaning that Novo Nordisk’s manufacturing capacity could now meet current and projected demand for the medication.
The FDA gave different types of facilities different deadlines to wind down their operations. Large-scale compounding facilities (called 503B outsourcing facilities) that Weight Watchers relied on had until May 22, 2025 to stop producing compounded semaglutide. Weight Watchers and similar companies couldn’t continue their programs because they depended on these mass-production facilities. When the regulations changed, their entire business model for these medications became unsustainable.
The Difference Between Corporate Medicine and Local Care
Large telehealth companies like Weight Watchers face restrictions that don’t apply to local medical practices in the same way. Weight Watchers partnered with 503B outsourcing facilities that could produce medications in large batches without individual patient prescriptions. This allowed them to offer standardized treatments at scale but left them vulnerable when regulations changed.
Local clinics like Alturas Medical Weight Loss work differently. We partner with smaller compounding pharmacies (called 503A facilities) that create patient-specific formulations based on individual medical needs. Under FDA regulations, 503A compounding pharmacies can continue creating customized medications when there’s a documented medical necessity for modifications that aren’t available in commercial products.
The key difference lies in personalized medicine versus mass production. Local providers can work with compounding pharmacies to create modifications such as alternative dosing schedules for patients who need different titration patterns, formulations without specific inactive ingredients for patients with allergies, addition of complementary ingredients like B vitamins and amino acids for muscle retention, or alternative concentrations for patients with specific medical needs. For these modifications to be legal, there must be documented medical necessity on the prescription, meaning your provider determines that the commercially available product cannot meet your specific medical needs.
The Impact on Patients
Many patients who were using Weight Watchers for their semaglutide treatment have found themselves in difficult situations. The sudden discontinuation has created several problems. Patients often face significant cost differences, with brand-name medications like Wegovy costing over $1,300 per month compared to the $129-189 that Weight Watchers charged for compounded versions.
Insurance coverage remains challenging, with most plans requiring prior authorization and many patients finding their coverage denied entirely. Even when patients can afford brand-name medications, they often discover that local pharmacies don’t have adequate supplies, despite the FDA declaring the shortage resolved.
Stopping GLP-1 medications abruptly can lead to rapid weight regain and return of appetite issues that these medications help control. This makes finding a smooth transition crucial for maintaining progress.
How Alturas Medical Continues Providing These Treatments
While large companies faced regulatory roadblocks, Alturas Medical Weight Loss can continue offering compounded semaglutide and tirzepatide through our approach to personalized medicine.
We have licensed providers who evaluate each patient individually. When our provider determines that a patient needs specific modifications not available in commercial products, we can legally provide those through qualified compounding pharmacies.
This might include patients who need gradual dose adjustments different from standard protocols, those with allergies to specific inactive ingredients, or patients who benefit from combined approaches with hormone therapy.
Unlike online-only programs, we provide ongoing medical supervision. Our providers monitor your progress, manage any side effects, and can adjust treatments as needed.
We also offer combined approaches, such as integrating GLP-1 medications with bioidentical hormone therapy for enhanced results, particularly for patients over 40 dealing with age-related hormonal changes.
Understanding the Regulatory Landscape
The situation with compounded GLP-1 medications continues to evolve, and it’s important to understand what’s legal and what isn’t. The FDA has made it clear that mass production of compounded GLP-1 medications is no longer permitted now that shortages have been declared resolved. However, patient-specific compounding for documented medical needs remains legal under Section 503A regulations.
Compounding pharmacies we work with must follow strict quality standards including USP guidelines and maintain proper certifications. While compounded medications aren’t FDA-approved like brand-name drugs, they’re still subject to state oversight and quality requirements.
Several factors will likely affect access to these medications going forward. Despite the FDA’s declaration that shortages are resolved, many healthcare providers report continued supply disruptions at the local level. This suggests that access issues may persist even for brand-name medications. With less competition from compounded versions, prices for brand-name medications may continue to rise. This could drive more patients to seek local solutions or potentially unsafe alternatives. The Outsourcing Facilities Association has filed lawsuits challenging the FDA’s shortage determinations, though courts have generally upheld the FDA’s decisions so far.
Making the Transition Successfully
If you’ve been affected by Weight Watchers discontinuing their compounded semaglutide program, here are important steps to consider. Don’t stop your current medication abruptly, as suddenly stopping GLP-1 medications can lead to rapid weight regain and return of appetite issues. Work with a qualified healthcare provider to ensure continuity of care.
Collect information about your current treatment including dosing, progress notes, and any side effects you’ve experienced. This will help a new provider understand your specific needs. Consider both brand-name medications (if insurance covers them) and legal compounded alternatives through local medical practices. Each has different advantages depending on your situation. Local providers can often offer additional services like hormone testing and therapy that might enhance your weight loss results beyond what large telehealth companies could provide.
Why Choose a Local Medical Practice
The recent regulatory changes highlight several advantages of working with local healthcare providers rather than large telehealth companies. Local medical practices aren’t subject to the same corporate pressures and regulatory vulnerabilities that affected large telehealth companies. We’re committed to long-term patient relationships rather than business model pivots.
Every patient is different, and local providers can customize treatments based on individual needs rather than offering one-size-fits-all solutions. Local practices can offer integrated approaches combining weight loss medications with other treatments like hormone therapy, nutritional counseling, and ongoing medical monitoring. Experienced local providers understand current regulations and can navigate the complex legal landscape to continue providing legal access to effective treatments.
What This Means for Your Weight Loss Journey
The end of Weight Watchers’ compounded semaglutide program doesn’t mean the end of affordable access to these life-changing medications. Local medical practices that understand current regulations can continue providing legal access to compounded GLP-1 medications for patients with documented medical needs.
Rather than viewing this as a setback, consider it an opportunity to establish care with a provider who can offer more comprehensive, personalized support for your long-term health goals. GLP-1 medications are powerful tools, but they work best as part of a comprehensive approach that includes proper medical monitoring, lifestyle support, and addressing underlying factors that contribute to weight gain.
If you need to transition from Weight Watchers or another telehealth company that has discontinued compounded GLP-1 services, don’t wait to establish new care. The sooner you connect with a local provider, the smoother your transition will be. Gaps in treatment can lead to setbacks in your progress. Discuss both compounded and brand-name options with your new provider, and take advantage of services that large telehealth companies couldn’t offer, such as hormone testing, nutritional counseling, and integrated approaches to weight management.
About Alturas Medical Weight Loss
As the regulatory landscape for weight loss medications continues to change, Alturas Medical Weight Loss remains committed to providing legal, safe access to effective treatments for patients throughout Idaho. We understand the frustration of having your treatment disrupted by corporate decisions. Our goal is to provide stable, long-term access to the medications and support you need for successful weight management.
We combine GLP-1 medications with comprehensive medical care, including hormone optimization, nutritional support, and ongoing monitoring to help you achieve and maintain your weight loss goals. We offer both in-person consultations at our Meridian clinic and virtual appointments for patients throughout Idaho. Our providers will evaluate your individual needs and determine the best approach for your situation.
Call (208) 579-6100 to schedule your consultation, visit us at 1532 W Cayuse Creek Dr, Meridian, ID 83646, or check out our Google Business profile for more information and patient reviews.
When large companies abandon patients due to regulatory changes, local medical practices remain committed to providing personalized, legal solutions for your health needs.
Frequently Asked Questions
When exactly did Weight Watchers stop offering compounded semaglutide? Weight Watchers officially stopped offering compounded semaglutide to new members on May 21, 2025. They announced this decision in response to FDA guidance that declared the semaglutide shortage resolved in February 2025. The company had to comply with regulations that no longer permitted large-scale compounding of these medications.
Why can’t I get compounded semaglutide from telehealth companies anymore? The FDA declared the semaglutide shortage officially resolved in February 2025, which meant that large-scale compounding facilities (503B outsourcing facilities) could no longer legally produce copies of the medication. These facilities had until May 22, 2025 to wind down operations. Most telehealth companies relied on these large facilities for their supply, so when the regulations changed, they had to stop offering compounded versions.
Are all compounded GLP-1 medications now illegal? No, but the rules have changed significantly. Mass-produced “copies” of commercially available drugs are no longer permitted. However, local compounding pharmacies can still create patient-specific formulations when there’s a documented medical need for modifications that aren’t available in commercial products, such as different dosing, alternative ingredients for allergies, or added components like B vitamins.
How much do brand-name medications cost compared to what I was paying? Brand-name medications like Wegovy and Ozempic typically cost $1,000-$1,300 per month without insurance, while compounded versions through companies like Weight Watchers cost $129-$189 per month. This significant price difference is why many patients are concerned about the transition.
Can local medical practices still legally provide compounded semaglutide? Yes, under specific circumstances. Local medical practices can work with 503A compounding pharmacies to create patient-specific formulations when a physician documents that the commercially available product cannot meet a patient’s specific medical needs. This might include custom dosing, formulations without certain inactive ingredients for patients with allergies, or combinations with other beneficial ingredients.
What alternatives exist if I can’t afford brand-name medications? Several options may be available depending on your situation. These include Zepbound vials (a more affordable version of tirzepatide), other FDA-approved weight loss medications like Saxenda or Contrave, insurance coverage assistance programs, or working with a local provider who can legally compound personalized formulations for documented medical needs.
Will my insurance cover brand-name GLP-1 medications? Insurance coverage varies significantly. Many plans require prior authorization, and about 83% of patients face additional requirements beyond a simple prescription. Some insurance plans have started covering these medications more broadly, but coverage for weight loss indications is still limited compared to diabetes indications.
How do I safely transition from compounded to brand-name medications? Don’t stop your current medication abruptly, as this can lead to rapid weight regain. Work with a healthcare provider to create a transition plan. They can help you obtain prescriptions for brand-name medications, explore insurance coverage options, or determine if you’re a candidate for legally compounded alternatives with documented medical modifications.
Are compounded medications actually unsafe? Compounded medications themselves aren’t inherently unsafe when made by qualified pharmacies following proper standards. However, they don’t undergo the same FDA approval process as brand-name drugs. The main concerns have been about dosing errors, quality control at some facilities, and patients obtaining medications from unregulated sources online.
What should I do if I can no longer afford my weight loss medication? Don’t simply stop taking the medication without medical guidance. Options include speaking with your doctor about patient assistance programs, exploring alternative FDA-approved weight loss medications, investigating insurance coverage possibilities, or consulting with a local medical practice that can legally provide personalized compounded alternatives when medically appropriate.
How can I tell if a provider is legally allowed to offer compounded GLP-1 medications? Legitimate providers should be able to explain the specific medical reasons why you need a customized formulation that differs from commercially available products. They should document these reasons on your prescription and work with licensed 503A compounding pharmacies. Be wary of providers offering “copies” of commercial products or mass-produced alternatives without documented patient-specific modifications.
Will compounded medications become available again in the future? This depends on several factors including ongoing legal challenges, potential future shortages of brand-name medications, and FDA policy changes. The Outsourcing Facilities Association has filed lawsuits challenging the FDA’s decisions, though courts have generally upheld the FDA’s determinations so far. Patient-specific compounding for documented medical needs will likely continue to be legal.
Important Disclaimer: This information is for educational purposes only and is not intended as medical advice. Individual results may vary significantly. All medications require a prescription following medical evaluation. Compounded medications are not FDA-approved and should only be used when there is a documented medical need that cannot be met by commercially available products.
